Finite-State Markov-Chain Approximations: A Hidden Markov Approach
Finance and Economics Discussion Series · 2023-06 · (2023-040) · 1-62
DOI: 10.17016/feds.2023.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Finance and Economics Discussion Series, 2023-06. Verfasst von Eva F. Janssens und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
This paper proposes a novel finite-state Markov chain approximation method for Markov processes with continuous support, providing both an optimal grid and transition probability matrix. The method can be used for multivariate processes, as well as non-stationary processes such as those with a life-cycle component. The method is based on minimizing the information loss between a Hidden Markov Model and the true data-generating process. We provide sufficient conditions under which this information loss can be made arbitrarily small if enough grid points are used. We compare our method to existing methods through the lens of an asset-pricing model, and a life-cycle consumption-savings model. We find our method leads to more parsimonious discretizations and more accurate solutions, and the discretization matters for the welfare costs of risk, the marginal propensities to consume, and the amount of wealth inequality a life-cycle model can generate.
Zitieren
APA
Janssens, E. F., & McCrary, S. (2023). Finite-State Markov-Chain Approximations: A Hidden Markov Approach. Finance and Economics Discussion Series, 1-62. https://doi.org/10.17016/feds.2023.040
Vancouver
Janssens EF, McCrary S. Finite-State Markov-Chain Approximations: A Hidden Markov Approach. Finance and Economics Discussion Series. 2023:1-62. doi:10.17016/feds.2023.040
BibTeX
@article{Janssens2023,
author = {Janssens, Eva F. and McCrary, Sean},
title = {Finite-State Markov-Chain Approximations: A Hidden Markov Approach},
journal = {Finance and Economics Discussion Series},
year = {2023},
number = {2023-040},
pages = {1--62},
doi = {10.17016/feds.2023.040}
}
EUVIMED